Interestingly, in non-small cell lung cancer, PD-L1 is also one of the molecules modulated during TGF-β-induced epithelial–mesenchymal transition (EMT), a key process in cancer progression in which epithelial cancer cells adopt a mesenchymal phenotype. Here, CD274 is linked to cancer.